alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: ajmar01@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:08:43 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Jennifer Blancas

Tomball, TX 77377
Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM

The Board of DirectorsLNB Bancorp,
Inc.:

We consent to the incorporation by
reference in the registration statement No. 33-65034, No. 333-125288, No.
333-115385, No. 333-133621 and No. 333-53210 on Form S-8 and No. 333-43441 and
No. 333-58414 on Form S-3 and 333-141580 on Form S-4 of LNB Bancorp, Inc. of our
report dated March 13, 2006, with respect to the consolidated statements of
income, shareholders equity and cash flows of LNB Bancorp, Inc. for the year
ended December 31, 2005, which report appears in the December 31, 2007 annual
report on Form 10-K of LNB Bancorp, Inc.



Cleveland, OhioMarch 17,
2008

---
#### Henry Knickerbocker, Plaintiff, v. Mary E. Decker, Defendant.

Order modified as directed in opinion, and affirmed as modified, without costs. Opinion *Per OuHam.*
Exhibit




























AMENDMENT AGREEMENT NO. 2


dated as of 29 March 2016


between


Meritor HVS AB 
as Seller


and


Viking Asset Purchaser No. 7 IC
an incorporated cell of Viking Global Finance ICC
as Purchaser


and 


Citicorp Trustee Company Limited 
as Programme Trustee


(the “Amendment Agreement”)






































		
	1.
	BACKGROUND AND DEFINITIONS


		
	1.1
	The parties hereto have entered into a receivables purchase agreement dated 28 June 2011 between Meritor HVS AB as Seller, Viking Asset Purchaser No. 7 IC, an incorporated cell of Viking Global Finance ICC, as Purchaser and Citicorp Trustee Company Limited as Programme Trustee as amended, restated and supplemented from time to time (the “Receivables Purchase Agreement”).


		
	1.2
	The parties now wish to amend the Receivables Purchase Agreement in accordance with the provisions set out herein.


		
	1.3
	Capitalised terms shall, unless the context otherwise requires, have the meaning given to them in the Receivables Purchase Agreement.


		
	2.
	AMENDMENT


		
	2.1
	The parties hereto agree that with effect as of the date of this Amendment Agreement the definition of Total Commitments under Clause 1.1 Definitions of the Receivables Purchase Agreement shall be amended as follows:


“Total Commitments” means the part of the aggregate of the Commitments as reserved by the Accounts Administrator to be used in relation to the Transaction, being EUR One hundred and fifty five million (155,000,000). The Total Commitments may (to the extent possible) be increased as agreed between the Seller and the Accounts Administrator from time to time.      
		
	1.
	MISCELLANEOUS


		
	1.4
	For the avoidance of doubt, the Receivables Purchase Agreement, as amended and extended from time to time, shall remain in full force and effect and the provisions set out in this Amendment Agreement shall only take effect as specified herein.


		
	1.5
	This Amendment Agreement may be executed in any number of counterparts and all such counterparts taken together shall be deemed to constitute one and the same instrument.




IN WITNESS WHEREOF the parties have executed this Amendment Agreement on the respective dates specified below with effect from the date specified in Clause 2.1 above.


For and behalf of
Meritor HVS AB
		
	By:
	/s/ Eric Moss_____________________


		
	Name:
	 Eric Moss


		
	Title:
	Authorized Signer


For and behalf of
Viking Asset Purchaser No. 7 IC
		
	By:
	/s/ M. Jabey_____________________


Name: M. Jabey
Title: Sweden


For and behalf of
Citicorp Trustee Company Limited
		
	By:
	/s/ David Mares_____________________


Name: David Mares
Title: Director
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                         174,955
<SECURITIES>                                   201,069
<RECEIVABLES>                                  200,315
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               630,060
<PP&E>                                         414,605
<DEPRECIATION>                                  61,157
<TOTAL-ASSETS>                               1,652,194
<CURRENT-LIABILITIES>                          463,994
<BONDS>                                        997,524
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           242
<OTHER-SE>                                      70,409
<TOTAL-LIABILITY-AND-EQUITY>                 1,652,194
<SALES>                                              0
<TOTAL-REVENUES>                               340,281
<CGS>                                          250,391
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                  (115)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              28,998
<INCOME-PRETAX>                                (56,964)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (56,964)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (56,964)
<EPS-PRIMARY>                                    (1.08)
<EPS-DILUTED>                                    (1.08)
        


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 7
       
<S>                                         <C>
<PERIOD-TYPE>                                     9-MOS
<FISCAL-YEAR-END>                           DEC-31-1997
<PERIOD-END>                                SEP-30-1997
<DEBT-HELD-FOR-SALE>                                  0
<DEBT-CARRYING-VALUE>                                 0
<DEBT-MARKET-VALUE>                                   0
<EQUITIES>                                            0
<MORTGAGE>                                            0
<REAL-ESTATE>                                         0
<TOTAL-INVEST>                                        0
<CASH>                                           17,684
<RECOVER-REINSURE>                                    0
<DEFERRED-ACQUISITION>                                0
<TOTAL-ASSETS>                                   19,384
<POLICY-LOSSES>                                       0
<UNEARNED-PREMIUMS>                                   0
<POLICY-OTHER>                                        0
<POLICY-HOLDER-FUNDS>                                 0
<NOTES-PAYABLE>                                  20,000
<PREFERRED-MANDATORY>                                 0
<PREFERRED>                                           0
<COMMON>                                              0
<OTHER-SE>                                       (1,921)
<TOTAL-LIABILITY-AND-EQUITY>                     19,384
<PREMIUMS>                                            0
<INVESTMENT-INCOME>                                   0
<INVESTMENT-GAINS>                                    0
<OTHER-INCOME>                                        0
<BENEFITS>                                            0
<UNDERWRITING-AMORTIZATION>                           0
<UNDERWRITING-OTHER>                                  0
<INCOME-PRETAX>                                  (1,484)
<INCOME-TAX>                                          0
<INCOME-CONTINUING>                              (1,484)
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                     (1,484)
<EPS-PRIMARY>                                         0
<EPS-DILUTED>                                         0
<RESERVE-OPEN>                                        0
<PROVISION-CURRENT>                                   0
<PROVISION-PRIOR>                                     0
<PAYMENTS-CURRENT>                                    0
<PAYMENTS-PRIOR>                                      0
<RESERVE-CLOSE>                                       0
<CUMULATIVE-DEFICIENCY>                               0
        

</TABLE>
Exhibit 99.2

CERTIFICATION

In connection with the Annual Report (the "Report") of Alliance Pharmaceutical Corp. (the "Company") on Form 10-K for the period ended
June 30, 2002, I, Tim T. Hart, the Chief Financial Officer of the Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, do hereby certify as follows:



Date:
September 27, 2002

|By: |  | /s/                                 |  | 
|--- |  | ----------------------------------- |  | 
|    |  | Tim T. Hart
Chief Financial Officer |  | 

---

QuickLinks
RESCISSION OF AMENDED AGREEMENT FOR THE EXCHANGE

                    OF STOCK AND MUTUAL RELEASE OF ALL CLAIMS

          An Amended  Agreement for the Exchange of Stock dated February 3, 1997
(the "Agreement") was entered by Eurotronics Holdings,  Inc., a Utah corporation
("Eurotronics"),  InterConnect  West,  Inc., a Utah  corporation  ("InterConnect
West"),  Mark Tolman,  an individual,  and certain other consultants who brought
these  parties  together   (Eurotronics,   InterConnect   West  and  Tolman  are
hereinafter  collectively  referred  to  as  the  "Parties").  Pursuant  to  the
Agreement,  Eurotronics  was to acquire  from Tolman all issued and  outstanding
shares of InterConnect  West, which would have made InterConnect West its wholly
owned subsidiary. Eurotronics was to issue 2,300,000 shares of its common stock,
par value  $0.0001,  to  Tolman  as  consideration  for his  delivery  of all of
InterConnect  West's common  shares.  These  transfers  and  issuances  have not
transpired  due to the lack of proper  funding,  delays in obtaining  regulatory
approval,  all of which  precluded the proper  approval by the  shareholders  of
Eurotronics.

          For valuable  consideration,  the receipt and sufficiency of which are
hereby acknowledged, the Parties hereby agree to rescind and terminate ab initio
the  February  3, 1997  Amended  Agreement  for the  Exchange  of Stock  because
material  conditions  in the Agreement  have not been  fulfilled and the Parties
have  determined  that the terms set forth in the Agreement are no longer in the
best  interests of any of the Parties.  The Parties agree not to be bound by the
terms of the Agreement, and further agree to hold one another harmless,  release
any and all  claims  against  one  another  stemming  from  the  Agreement,  and
indemnify  one another with respect to any  obligations  arising  pursuant to or
from the Agreement.  These releases do not include  expenditures Tolman has made
on  behalf  of  Eurotronics,  which  amounts  are  still  payable  to  Tolman by
Eurotronics and referenced in the attached Exhibit A.

          All Parties  agree to waive any  interests in any shares that have not
been issued and transferred,  particularly the Eurotronics  shares to Tolman and
the InterConnect West shares to Eurotronics.  The recission contemplated in this
document is complete upon the signing of the Parties.


/s/ Mel Fields                              /s/ Paul Burke 
Mel Fields, Director                            Paul Burke, Director
Eurotronics Holdings, Inc.                      Eurotronics Holdings, Inc.


/s/ Mark Tolman                             /s/ Mark Tolman
Mark Tolman                                     Mark Tolman, President
                                                InterConnect West, Inc.
Here's how you know
 **Official websites use .mil** .mil
 **Secure .mil websites use HTTPS** lock () https://


Skip to main content (Press Enter).
 Toggle navigation
            
            U.S. Central Command
                CENTCOM
        Search
                    Search CENTCOM:
                        Search
                Search CENTCOM:
                    Search
    Home

    ABOUT US
    
        COMMAND PRIORITIES

    LEADERSHIP

    COMPONENT COMMANDS

    HISTORY

    POSTURE STATEMENT

    CENTCOM AOR
    
        CENTCOM COALITION

    OPERATIONS AND EXERCISES
    
        USMTM

    CIVILIAN CASUALTY REPORT

    CONTACT
    
        OPERATIONAL CONTRACT SUPPORT

    COMMUNITY RELATIONS

    THEATRE MEDICAL CLEARANCE

    INNOVATION VENDOR PORTAL

    MILITARY MEMBER INNOVATION PORTAL

    MEDIA
    
        SOCIAL MEDIA

    NEWS ARTICLES

    PRESS RELEASES

    STATEMENTS

    IMAGERY

    VIDEOS

    TRANSCRIPTS

    VISITORS AND PERSONNEL
    
        FAMILY CENTER

    FAMILY READINESS

    CENTCOM WEBMAIL

    SOCIAL MEDIA SECURITY

    ACCOUNTABILITY

    EMERGENCY PREPAREDNESS

    USCENTCOM UNCLASSIFIED REGULATIONS

    FOIA LIBRARY

    INNOVATION OASIS

    WELCOME GUIDE  Search
 Search
 All Images All ImagesCommunity RelationsOtherPreviousCommanders
 Upload Date Upload DatePhoto DateTitle
  Share
  
 Small () Medium () Full Size (1.18 MB)
 
 Amphibious Squadron 4 LSD 50 Carter Hall Marine Expeditionary Unit 24th MEU Iwo Jima ARG
 Photo Gallery
 About UsCommand PrioritiesLeadershipComponent
   CommandsHistoryPosture Statement
   Area of
   ResponsibilityCENTCOM Coalition
   Operations And
   ExercisesOperation Inherent
   ResolveResolute Support
   MediaSocial MediaNews ArticlesPress ReleasesVideo And Imagery
   Visitors And
   PersonnelFamily ReadinessCENTCOM WebmailSocial MediaSecurityAccountabilityEmergency
   Preparedness
   ContactCommunity Relations
                    Stay Connected
                
                Privacy & Security  Inspector General  FOIA  Privacy Act
            

Hosted by Defense Media Activity - WEB.mil
From: nancycb700@gmail.com on behalf of Nancy Bleeker

To: E-OHPSCA2713.EBSA

Subject: Women"s health -Accept the IOM recommendations

Date: Saturday, August 13, 2011 2:39:34 PM

I join with the American Association of University Women (AAUW) in asking you to accept the

recommendations of the Institute of Medicine as pertain to coverage of preventive care under the

new health care law, and to reject any exemptions for “religious employers.” These preventive

services are a critical element of the new law and would provide countless women better access

to necessary health care.

While AAUW believes that “religious refusal” exemptions unjustly deny women access to

contraceptive services, others, driven by an ideological distaste for all contraceptive services, are

pushing the government to make exemptions even larger. Indeed, some groups are pushing for

the exemption to apply to religiously-run health providers, so hospitals with religious

affiliations would be exempt from the coverage requirement, even though they employ people of

all faiths and ideologies. If granted, this larger exemption would deny access to thousands of

women just because of where they work.

I urge you to ensure women have access to quality preventive care by accepting IOM’s

recommendations and rejecting the proposed religious refusal exemption provisions.
EXHIBIT 21


                             LIST OF SUBSIDIARIES OF
                       FRONTIER ADJUSTERS OF AMERICA, INC.
                       -----------------------------------




<TABLE>
<CAPTION>
Name                                 State of Incorporation             Parent Company                       
--------------------------------     ----------------------             --------------------------------     

<S>                                   <C>                               <C>
Frontier Adjusters of Arizona, Inc.   Arizona                           Frontier Adjusters of America, Inc.



Frontier Adjusters, Inc.              Colorado                          Frontier Adjusters of Arizona, Inc.



Frontier Adjusters Co., Ltd.          Alberta, Canada                   Frontier Adjusters, Inc.
</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Special Emphasis Panel; Bioinformatics Drug Repositioning and Combination Therapy for AD.                    

*Date:*                         October 23, 2023.                    

*Time:*                         12:00 p.m. to 4:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Mariel Jais, Ph.D., M.D., Scientific Review Officer, Scientific Review Branch, National Institutes of Health, National Institute on Aging, 7201 Wisconsin Avenue, RM: 2E400, Bethesda, MD 20892,                         *mariel.jais@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: September 14, 2023.

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-20246 Filed 9-18-23; 8:45 am]

BILLING CODE 4140-01-P
IV 

House Calendar No. 241 

110TH CONGRESS 

2D SESSION H. RES. 1297 

[Report No. 110–731] 

Providing for consideration of the bill (H.R. 6275) to amend the Internal 

Revenue Code of 1986 to provide individuals temporary relief from the 

alternative minimum tax, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 24, 2008 

Mr. WELCH of Vermont, from the Committee on Rules, reported the following 

resolution; which was referred to the House Calendar and ordered to be 

printed 

RESOLUTION 

Providing for consideration of the bill (H.R. 6275) to amend 

the Internal Revenue Code of 1986 to provide individuals 

temporary relief from the alternative minimum tax, and 

for other purposes. 

1 Resolved, That upon the adoption of this resolution 

2 it shall be in order to consider in the House the bill (H.R. 

3 6275) to amend the Internal Revenue Code of 1986 to 

4 provide individuals temporary relief from the alternative 

5 minimum tax, and for other purposes. All points of order 


rwilkins on PROD1PC63 with BILLS
2 

•HRES 1297 RH 

1 against consideration of the bill are waived except those 

2 arising under clause 9 or 10 of rule XXI. The amendment 

3 in the nature of a substitute recommended by the Com4 mittee on Ways and Means now printed in the bill shall 

5 be considered as adopted. The bill, as amended, shall be 

6 considered as read. All points of order against provisions 

7 of the bill, as amended, are waived. The previous question 

8 shall be considered as ordered on the bill, as amended, 

9 to final passage without intervening motion except: (1) one 

10 hour of debate equally divided and controlled by the chair11 man and ranking minority member of the Committee on 

12 Ways and Means; and (2) one motion to recommit with 

13 or without instructions. 

14 SEC. 2. During consideration of H.R. 6275 pursuant 

15 to this resolution, notwithstanding the operation of the 

16 previous question, the Chair may postpone further consid17 eration of the bill to such time as may be designated by 

18 the Speaker. 


rwilkins on PROD1PC63 with BILLS

rwilkins on PROD1PC63 with BILLS
House Calendar No. 241 

110TH CONGRESS 

2D SESSION H. RES. 1297 

[Report No. 110

–731] 

RESOLUTION 

Providing for consideration of the bill (H.R. 6275) 

ternative minimum tax, and for other purposes. provide individuals temporary relief from the alto amend the Internal Revenue Code of 1986 to 

JUNE 24, 2008 

Referred to the House Calendar and ordered to be 

printed 


rwilkins on PROD1PC63 with BILLS